Top

Reactions Weekly

Published in:

01-04-2024 | Cytokines | Case report

Anti-GD2-chimeric-antigen-receptor-T-cell-therapy-Sinobioway-Cell-Therapy/prostate-specific-membrane-antigen-CAR-T-cell-therapy-Shanghai-Bioray-Laboratory-Inc

Cytokine release syndrome

Published in: Reactions Weekly | Issue 1/2024

Excerpt

Author Information

An event is serious (based on the ICH definition) when the patient outcome is:

* death
* life-threatening
* hospitalisation
* disability
* congenital anomaly
* other medically important event

…

Wang K, et al. CAR-T Therapy for a Child with Refractory Inflammatory Myofibroblastic Tumor. Blood 140 (Suppl. 1) : 10355-10356, Nov 2022. Available from: URL: https://dx.doi.org/10.1182/blood-2022-165248 [abstract]

Title: Anti-GD2-chimeric-antigen-receptor-T-cell-therapy-Sinobioway-Cell-Therapy/prostate-specific-membrane-antigen-CAR-T-cell-therapy-Shanghai-Bioray-Laboratory-Inc
Cytokine release syndrome
Publication date: 01-04-2024
Publisher: Springer International Publishing
Keyword: Cytokines
Published in: Reactions Weekly / Issue 1/2024
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-024-55423-1

At a glance: The STEP trials

Springer Medicine

Anti-GD2-chimeric-antigen-receptor-T-cell-therapy-Sinobioway-Cell-Therapy/prostate-specific-membrane-antigen-CAR-T-cell-therapy-Shanghai-Bioray-Laboratory-Inc

Cytokine release syndrome

Excerpt

At a glance: The STEP trials

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2024

Sildenafil

Bromocriptine/cabergoline/quinagolide

Potassium/zonisamide

Perindopril

Tamoxifen

Yttrium-90